Literature DB >> 10092103

DNA immunization confers systemic, but not mucosal, protection against enteroinvasive bacteria.

A Noll1, N Bücheler, E Bohn, R Schirmbeck, J Reimann, I B Autenrieth.   

Abstract

Naked plasmid DNA (pRc/Y-hsp60) with a cytomegalovirus promoter and a sequence encoding Yersinia enterocolitica 60-kDa heat shock protein (Y-HSP60) was used for vaccination. After intramuscular injection of pRc/Y-hsp60, Y-hsp60 mRNA could be detected by reverse transcription-PCR in muscle, liver and spleen. A single immunization with pRc/Y-hsp60 induced significant Y-HSP60-specific T cell responses after 1 week. IFN-gamma production by spleen cells upon stimulation with Y-HSP60 was strictly dependent on the presence of CD4+ T cells, indicating the generation of a Th1 response upon DNA immunization. DNA immunization in addition induced strong Y-HSP60-specific IgG2a, weak IgG1, but not IgA antibodies. Immunization of BALB/c and C57BL/6 mice with pRc/Y-hsp60 conferred protection against disseminated Y. enterocolitica infection in spleen, but not at the site of mucosal entry, the Peyer's patches. Furthermore, pRc/Y-hsp60 vaccination did not induce cross-protection against related pathogens. Vaccination of beta2-microglobulin- and H2-I-Abeta-deficient mice was not protective, suggesting that both CD4+ and CD8+ T cells are required for protective immunity induced by DNA vaccination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092103     DOI: 10.1002/(SICI)1521-4141(199903)29:03<986::AID-IMMU986>3.0.CO;2-9

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

1.  Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.

Authors:  Liljana Stevceva; Xavier Alvarez; Andrew A Lackner; Elzbieta Tryniszewska; Brian Kelsall; Janos Nacsa; Jim Tartaglia; Warren Strober; Genoveffa Franchini
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  M cell-targeted DNA vaccination.

Authors:  Y Wu; X Wang; K L Csencsits; A Haddad; N Walters; D W Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

3.  Pharmacokinetics of plasmid DNA in the rat.

Authors:  B E Houk; R Martin; G Hochhaus; J A Hughes
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

4.  Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.

Authors:  G I Sanchez; M Sedegah; W O Rogers; T R Jones; J Sacci; A Witney; D J Carucci; N Kumar; S L Hoffman
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 5.  Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria.

Authors:  Anke Osterloh
Journal:  Vaccines (Basel)       Date:  2022-05-10

6.  Protection afforded by heat shock protein 60 from Francisella tularensis is due to copurified lipopolysaccharide.

Authors:  M G Hartley; M Green; G Choules; D Rogers; D G C Rees; S Newstead; A Sjostedt; R W Titball
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

7.  Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs.

Authors:  Lúcia de Paula; Célio L Silva; Daniela Carlos; Camila Matias-Peres; Carlos A Sorgi; Edson G Soares; Patrícia R M Souza; Carlos R Z Bladés; Fábio C S Galleti; Vânia L D Bonato; Eduardo D C Gonçalves; Erika V G Silva; Lúcia H Faccioli
Journal:  Genet Vaccines Ther       Date:  2007-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.